San Francisco, CA, United States of America

Lee Heil Chae

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Lee Heil Chae: Innovator in Metabolic Modulation

Introduction

Lee Heil Chae is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of metabolic health, holding a total of 7 patents. His work focuses on innovative methods for modulating metabolism and addressing various metabolic disorders.

Latest Patents

One of Lee Heil Chae's latest patents is a method for modulating metabolism. This method involves providing a consumable composition that includes an extract containing a specific compound to individuals in need. This approach aims to modulate metabolism and tackle the underlying issues associated with metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and type II diabetes mellitus. Another notable patent is related to an extract, consumable product, and method for enriching bioactive metabolites. This disclosure outlines methods and compositions that enhance levels of tyramine-containing hydroxycinnamic acid amides, along with methods for producing consumable products enriched with these compounds.

Career Highlights

Throughout his career, Lee Heil Chae has worked with notable companies, including Brightseed, Inc. and Hampton Creek, Inc. His innovative approaches have positioned him as a key player in the field of metabolic health.

Collaborations

Lee has collaborated with several professionals in his field, including Josh Stephen Tetrick and Meng Xu. Their combined expertise has contributed to the advancement of research and development in metabolic modulation.

Conclusion

Lee Heil Chae's contributions to the field of metabolic health through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in addressing metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…